Analystreport

Axovant Gene Therapies Ltd (NASDAQ: AXGT) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.

Axovant Gene Therapies Ltd.  (AXGT) 
Last axovant gene therapies ltd. earnings: 2/10 06:00 am Check Earnings Report